Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Outbreaks of lumpy skin disease in Greece
cows
It is thought the outbreaks may have have been vector spread from recent outbreaks in Turkey.
Disease reported in the EU for the first time
 
Outbreaks of lumpy skin disease have been confirmed in the EU for the first time.

The first outbreaks in Greece were reported to the World Organisation for Animal Health on 21 August. Since then, more than 40 cases have been confirmed in the Evros region of the country, which is on the European border with Turkey. Nearly 600 cows have now been culled.

Lumpy skin disease is a potentially fatal pox disease of cattle. It has economic implications as it can cause a temporary drop in milk production, temporary or permanent sterility in bulls and hide damage.

The source of the outbreaks in Greece has not yet been confirmed, but Defra's International Disease Monitoring team says it is likely to be vector spread from recent outbreaks in Turkey.

Cases of the disease have been reported regularly in Turkey since 2013, but it was confirmed in June this year that it had spread to the European side of the country.

As well as culling of infected animals, other disease control measures include movement restrictions and a 20km surveillance zone in Greece. There is currently no approved vaccine for the disease in the EU.

The risk of lumpy skin disease, goat pox or sheep pox entering the UK through imported skins or hides is thought to be low, according to a risk assessment commissioned by Defra last year.

Nonetheless, the outbreaks raise concerns about transboundary diseases and the effectiveness of current controls.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.